KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Aurora Cannabis (ACB) EBITDA Margin (2017 - 2025)

Aurora Cannabis has reported EBITDA Margin over the past 9 years, most recently at 1.01% for Q4 2025.

  • Quarterly EBITDA Margin fell 3172.0% to 1.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 26.54% through Dec 2025, down 3028.0% year-over-year, with the annual reading at 1.44% for FY2025, 543.0% down from the prior year.
  • EBITDA Margin was 1.01% for Q4 2025 at Aurora Cannabis, up from 58.81% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 85.99% in Q1 2021 and troughed at 1243.94% in Q2 2022.
  • The 5-year median for EBITDA Margin is 13.09% (2021), against an average of 83.39%.
  • Year-over-year, EBITDA Margin soared 1479458bps in 2021 and then tumbled -121170bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 10.29% in 2021, then crashed by -1008bps to 114.0% in 2022, then surged by 110bps to 10.93% in 2023, then skyrocketed by 181bps to 30.72% in 2024, then crashed by -103bps to 1.01% in 2025.
  • Per Business Quant, the three most recent readings for ACB's EBITDA Margin are 1.01% (Q4 2025), 58.81% (Q3 2025), and 20.96% (Q2 2025).